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Macrophages represent a  major source of cyclo-oxygenase and lipoxygenase prod- 
ucts  (1,  2).  In recent reports we established a  set of defined conditions for the rapid 
and  quantitative  determination  of these arachidonic  acid  (20:4) 1 metabolites using 
macrophages prelabeled with tritiated 20:4  (1,2).  With these procedures, it has been 
possible to define the relationship between phagocytosis and prostaglandin synthesis 
(1)  or leukotriene C  production  (2)  and  the role of specific phases of the phagocytic 
process in the initiation of 20:4 metabolism (3). 
It is well established that the secretory activities of the macrophage are dependent 
upon the in vivo environment (4-6) and that both elicited and activated macrophages 
secrete  products  not  released  by  resident  cells  (7).  In  this  paper,  we  examine  the 
production of 20:4 oxygenated products by murine peritoneal macrophages stimulated 
in  vivo by both  inflammatory and  immunologic  agents and  stimulated in  vitro by 
lymphokines. Our results emphasize that diminished macrophage 20:4 metabolism is 
a  consequence of the in vivo activated state. 
Materials  and  Methods 
Macrophages.  Normal peritoneal macrophages were established from cells of 25-30 g female 
Swiss-Webster mice (Taconic Farms, Germantown, NY) or from ICR mice (Trudeau Institute, 
Saranac  Lake,  NY).  Proteose peptone  (PP),  heart  infusion broth  (HIB),  and  thioglycollate 
(THIO)-elicited macrophages were obtained from  mice injected intraperitoneally (i.p.)  4  d 
earlier with  1 ml of phosphate-buffered saline containing a  1% (wt/vol) solution of PP or HIB 
and a  4%  (wt/vol) solution of THIO, all from Difco Laboratories, Detroit, MI. Cornebactenum 
parvum  (CP)-activated cells were obtained  11-14 d  after either an i.p. or an intravenous (i.v.) 
injection with  1.4 mg of formalin-killed CP  (Coparvax, Burroughs Wellcome, Co.,  Research 
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Triangle Park, NC). Where appropriate, animals injected i.p. or i.v. with CP were boosted i.p. 
with 1.4 mg of CP or with 1 ×  107to 2 ×  107 heat-killed Pasteur type Bacille Calmette-Gu6rin 
(BCG) 3 d before harvesting the macrophages. Macrophages were also taken 3-4 wk after mice 
were in~ected either i.p. or i.v. with 2 X 107 viable BCG. Boosted animals were injected i.p. with 
2 ×  10  autoclaved BCG 3 d before harvest. 
Macrophage Cultivation.  Primary cultures were established from peritoneal exudates as de- 
scribed by Cohn and Benson (8). Approximately 6 ×  l0  s resident peritoneal cells or 10 ×  106 
cells from treated mice were suspended in 1 ml of minimum essential alpha medium (a-MEM, 
Gibco, Grand Island Biological Co., Grand Island, NY) containing 10% fetal calf serum (FCS) 
and added to 35-mm diam plastic culture dishes.  After 2 h at 37°C in 5% CO2/95% air, the 
cultures were washed three times in calcium- and magnesium-free phosphate-buffered saline 
(PD) to remove nonadherent cells and incubated overnight in fresh ct-MEM plus 10% FCS or 
a-MEM plus 10% FCS and lymphokine. Fresh media were added daily. 
Lymphokine-activated Macrophages.  BCG-stimulated spleen cell supernates were prepared as 
described (9) and stored at -70°C after sterilization by filtration. Control supernatants were 
obtained from cultures of spleen cells from normal mice incubated with autoclaved BCG or 
alone. 
Synthesis of 20:4 Oxygenated Metabolites.  Macrophage cultures maintained in 0t-MEM and 
10%  FCS were labeled for  16 h  with 0.5 #Ci of [5,6,8,9,11,12,14,15-aH]20:4  ([aH]20:4,  62.2 
Ci/mmol, sp act; New England Nuclear, Boston, MA). At the end of the labeling period, the 
cultures  were  washed  three  times  with  PD,  overlaid  with  a-MEM  (no  serum),  and  the 
phagocytic stimulus added to initiate 20:4 release and metabolism. Media were removed after 
incubation for the appropriate periods under 5% CO2/95% air at 37°C. Cell monolayers were 
scraped into 1 ml of 0.05% Triton X-100 (Rohm and Haas, Co., Philadelphia, PA), and protein 
was determined by the method of Lowry et al. (10), with bovine serum albumin as the standard. 
Aliquots of media and Triton X-100 cell lysates were removed for radioactivity determinations. 
20:4 oxygenated products were extracted from culture media following a modification of the 
procedure described by Unger et al. (11). In brief, 1 vol of absolute ethanol was added. After 
acidification with formic acid  (85% wt/wt;  10 gl/ml of medium, final pH  ~3), media were 
extracted twice with 1 vol each of chloroform. The chloroform phases were combined and taken 
to dryness under a  stream of nitrogen. This procedure was  repeated  twice before the  20:4 
metabolites were dissolved in 0.5 ml of the appropriate starting buffer for silicie acid chroma- 
tography or reverse-phase high performance liquid chromatography (HPLC). 
Prostaglandins were separated from lipoxygenase products and unreacted 20:4 by chroma- 
tography of concentrated chloroform extracts on 0.3-g columns of silicic acid (Unisil; 100-200 
mesh, Clarkson Chemical Co., Williamsport, PA). Hydroxy-eicosatetraenoic acids (HETE) and 
unreacted  20:4  were  eluted with  15  ml  of chloroform.  Subsequently, prostaglandins were 
recovered by etution with  10 ml of 5.0% methanol in chloroform. The solvent fractions were 
routinely collected  into scintillation vials.  After removal of solvents under a  stream  of air, 
radioactivity was measured by liquid scintillation  counting  in Hydrofluor (National Diagnostics 
Inc., Advanced Applications Institute, Inc., Sommerville, NJ). 
For estimates of the total 20:4 oxygenated metabolites formed by macrophages, concentrated 
media extracts were subjected to HPLC. Columns (4.6-ram × 25-cm) of uhrasphere C-18 (Altex 
Scientific Inc., Subsid. of Beckman Instruments, Inc., Berkeley,  CA) were eluted isocratically 
with 80 ml of solvent 1 (methanol/water/acetic acid, 75/25/0.01, vol/vol/vol) followed  by 40 
ml of solvent 2 (methanol/acetic acid,  100/0.01,  vol/vol) at a flow rate of 1 ml/min. For the 
identification of prostaglandins, fractions 4-10 were pooled and evaporated under nitrogen. 
The residues were redissolved in 0.5 ml of solvent 3 (water/acetonitrile/benzene/aeetic acid, 
76.7/23.0/0.2/0.1,  vol/vol/vol/vol) and  subjected  to  HPLC  on  ultrasphere  C-18  columns 
eluted isocratically at a flow rate of 1 ml/min with solvent 3 (12). 
Quantitation of 20:4 Metabolites.  The molar quantities of 20:4 and 20:4 metabolites released 
by  [SH]20:4-1abeled  resident  macrophages  challenged  with  a  phagocytic  stimulus can  be 
accurately calculated from their radiolabel content, provided the specific activity of 20:4 in cell 
phospholipids is accurately known (1). The latter value is readily obtained from the phospho- 
lipid content  (172  pmol/#g of cell  protein)  (13) and  the  20:4 content  (25  tool  percent  of 
phospholipid fatty acids)  (1),  together with the quantity of incorporated 20:4.  Independent 1150  ACTIVATED  MACROPttAGE ARACItlDONIC ACID  METABOLISM 
criteria,  including fatty acid analysis, radioimmunoassay, and amino acid analysis, indicated 
radiolabel measurements provide an accurate (80% agreement) estimate of 20:4 release,  PGEz 
synthesis,  and LTC production, respectively (1, 2). The radiolabel content of 20:4 metabolites 
recovered from silicic  acid columns or HPLC was converted to pmol 20:4 metabolite//~g cell 
protein by the following formula (14): 
pmol of 20:4 metabolite 
/zg cell protein 
dpm~ 
dpm~ 
x  122.85, 
where dpm~  is the radiolabel  content of the 20:4 metabolite,  dpm2 is the total  radioactivity 
incorporated by cells, and  122.85 is a constant that includes the specific activity of 20:4 in cell 
phospholipid. Values for 20:4 metabolites were corrected for overall recoveries  obtained alter 
extraction and chromatography, as described previously (14). Total 20:4 release  was the total 
quantity  of radiolabel  released  by cells  after  a  phagocytic stimulus.  Molar  quantities  were 
calculated from the above formula using the total radiolabel in the medium as dpml. 
Radiolabeled 20:4 Metabolite Standards.  HPLC of all-labeled  standards was used to identify 
macrophage-derived 20:4 metabolites. [5,6,8,11,12,14,15-aH]PGE2,  [5,8,9,11,12,14,15-aH]6-keto 
PGF~,,  [5,6,8,9,11,12,14,15-aH]PGF2~,  and  [5,6,8,9,11,12,14,15-aH]thromboxane  B2  (TXB2) 
were  purchased  from  New  England  Nuclear.  all-labeled  5-HETE,  12-HETE,  and 
15-HETE were generated by published  procedures using [aH]20:4 as the substrate.  5-HETE 
was isolated from human neutrophils exposed to calcium ionophore A 23187  (15),  12-HETE 
from human  platelets  similarly stimulated  (16),  and  15-HETE after  incubation of [aH]20:4 
with soybean lipoxygenase (17).  12-HETE and  15-HETE were extracted as described above. 
5-HETE was extracted by the procedure described by Borgeat and Samuelsson (15). All three 
HETE were purified by HPLC in solvent  1. The elution times were 45-57, 38-39, and 34-35 
min for 5-HETE,  12-HETE, and  15-HETE, respectively. 
Fatty Acid Analysis.  Macrophage monolayers were rinsed into isotonic saline,  and the lipids 
were extracted as described (1). Fatty acid methyl esters were prepared by transesterification in 
methanolic HCI (13). The methyl esters  were then analyzed by gas-liquid chromatography on 
1/8-in X  10-ft columns of 10% SP-2330 on Chromosorb WA/W (Supelco, Inc., Bellefonte,  PA) 
at  180 ° with a carrier gas-flow rate of 30 ml/min. 
Phagocytic Stimuli.  Zymosan was purchased from ICN K and K Laboratories, Inc., Plainview, 
NY,  Stock  solutions  of zymosan were  prepared  in  an  a-MEM  (18).  Formalin-treated  CP 
(Coparvax, Burroughs Wellcome Co.) was centrifuged at 3,000 g for 20 rain and suspended at 
a final concentration of 7 mg/ml. Stock solutions (7 mg/ml) of lyophilized BCG were prepared 
in a-MEM plus 0.05% Tween 80 and sonicated. 
Results 
In  Vivo Stimulation  of Macrophages:  Nonspecific  Inflammatory  Agents.  Macrophages 
elicited with either PP or HIB released comparable amounts (100-110%)  of 20:4 and 
its  oxygenated products  as  did  resident  cells.  However,  THIO  cells  yielded  greatly 
reduced amounts of 20:4 metabolites  (10% of resident  cells), as noted by others  (19). 
This effect could be reproduced by exposing resident  macrophages in vitro to THIO 
(5 mg/ml)  for 16 h with a >50% inhibition of 20:4 metabolism. Other eliciting agents 
used in this study (PP or HIB) were without effect on macrophage 20:4 metabolism. 
In vivo Activation of Macrophages: Agents Evoking  Cell-mediated Immunity.  Macrophage 
populations obtained from animals after an i.p. delivery of CP demonstrated reduced 
levels of 20:4 metabolism.  This  is  illustrated  in  Fig.  1, which shows maximum  20:4 
release and prostaglandin synthesis by these cells and resident macrophages triggered 
with  a  maximum  phagocytic  stimulus  of  160  /~g  zymosan.  Resident  cells  released 
23.8-26.6  pmol  20:4//~g  cell  protein,  compared  with  6.3-12.6  pmol  20:4/pg  cell 
protein  for  i.p.  CP  macrophages.  Our  impression  from  many  experiments  is  that SCOTF ET  AL.  1151 
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FiG.  1.  20:4 release and  prostaglandin  synthesis by resident  and  in  vivo activated BCG, CP 
macrophages challenged with a maximum  challenge of 160 #g unopsonized zymosan. Cells were 
purified by adherence, labeled with [~H]20:4 for 16 h in a-MEM plus 10% FCS, and exposed to 
zymosan for 90 min in a-MEM. 20:4 release was determined from the radiolabel content of medium, 
and prostaglandin  synthesis was determined  from the radiolabel  content  of silicic acid column 
eluates  (5% methanol  in chloroform). Injection procedures were those described in Materials and 
Methods, except for the two right panels in which nonimmune  animals were injected 3 d before 
harvest of the peritoneal  cells. 20:4 release is represented  by the total height  of each  bar, and 
prostaglandin synthesis is represented as the height of the shaded area. 
specific pathogen-free mice exhibited the  greatest  inhibition of 20:4  metabolism to 
bacterial vaccines. 
As we noted previously (1), resident macrophages converted >80% of the released 
20:4 to oxygenated products, one-half of which were prostaglandins  (Fig.  1).  IP CP 
macrophages, in addition to diminished 20:4 release, converted a  smaller percentage 
(25%) of the released 20:4 to prostaglandins than did resident cells. 
Fig.  1  further  illustrates that  the  route  by  which  animals  are  immunized  is  an 
important determinant of macrophage 20:4 metabolism. 20:4 release and prostaglan- 
din production by i.v. CP macrophages, in contrast to i.p. CP cells, was comparable 
to those of resident macrophages or somewhat elevated (100-130%, n =  3).  Intraper- 
itoneal boosting of animals previously injected with CP (i.v. or i.p.) effectively reduced 
peritoneal macrophage 20:4 metabolism to the same low level, wh!ch was 30% of i.p. 
CP cultures. The effect of the boost was more striking on i.v. CP than on i.p. CP cells 
because of the higher capacity of the former cultures to form 20:4 oxgenated products 
when  challenged with  zymosan.  Immunologic  specificity was  not  required  because 
both  i.p.  BCG  and  i.p.  CP  boosts  were  equally  effective  (Fig.  1).  Macrophages 
harvested from nonimmune  mice injected i.p. with the boosting dose of CP or BCG 
3  d  before harvest  displayed less severe reductions  in  20:4  metabolism.  It appeared 
that  both sensitization of the host with  the vaccine as well as a  local inflammatory 
response, perhaps a  phagocytic event, were required for maximum reduction of 20:4 
metabolism. 
Kinetics  of 20:4  Release and Prostaglandin Synthesis.  Time-course  experiments  sup- 
ported the observation (Fig.  1)  that i.p. CP cells were less effective in producing 20:4 
metabolites. Although the kinetics of 20:4 release and prostaglandin synthesis by i.p. 
CP  and resident  macrophages were similar in that  both  were  linear for 60-90  rain, 1152  ACTIVATED  MACROPHAGE  ARACHIDONIC ACID  METABOLISM 
the initial rates of release by i.p. CP cells were reduced (Fig. 2), which accounted for 
the diminished production of 20:4 metabolites. Nevei'theless, the experiment in Fig. 
3 demonstrated that i.p. CP macrophages retained the capacity to respond to multiple 
exposures of zymosan by initiating  new  rounds  of 20:4  release  and  prostaglandin 
synthesis, as shown previously for resident macrophages (1). Both macrophage popu- 
lations remained responsive provided maximum levels of ingestion were not reached. 
However, for each dose of zymosan, the response of i.p. CP cells was quantitatively 
less than that of resident cell controls. 
20.'4 Metabolism as a Function of Culture Time.  The quantities of zymosan-induced 
20:4  release  and  prostaglandin  synthesis  by  i.p.  CP  and  resident  macrophages 
remained essentially constant over a 4-d period in culture (Fig. 4), indicating that the 
low levels of 20:4 metabolism by i.p. CP cells were not reversed by prolonged in vitro 
cultivation. 
20.'4 Content of  Macrophages.  An i.p. injection of bacterial vaccines exposes peritoneal 
macrophages  to  particles  that  may  promote  20:4  release  in  vivo  and  result  in  a 
decreased  content  of 20:4  in  cell  phospholipid.  Clearly,  this  could  contribute  to 
diminished  20:4 release  in  response  to  an  in  vitro phagocytic challenge.  The data 
presented in Table I  indicated that, although differences in phospholipid fatty acid 
composition were evident between resident and i.p. CP cells, the 20:4 contents were 
similar and would not account for the differences in 20:4 metabolite production. 
20:4 Metabolites Synthesized by i.p. CP Macrophages.  Fig. 5 compares HPLC profiles 
of 20:4 metabolites synthesized by i.p. CP  and resident cells under conditions that 
allow mutual separation of prostaglandins and lipoxygenase products. The profiles of 
resident cell products were  dominated  by a  large peak of radiolabel  in  the runoff 
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Fxc. 3.  Restimulation  of i.p.  CP  macrophag  e  20:4 release  (top)  and  prostaglandin  synthesis 
(bottom). After the 16-h labeling period with 0.5 #Ci [aH]20:4, the cultures were exposed to 60 p,g 
of zymosan at t =  0 in a-MEM (no serum). Media were removed from duplicate cultures at the 
indicated times and processed as described in Fig. 2. An additional 100/lg of zymosan was added to 
the remaining cultures  at 90 min  (arrow). The media were harvested  at subsequent  times and 
processed. Values are the means ztz range. Similar results were obtained in two separate experiments. 
volume  of the  column  that  consists of prostaglandins  (80%)  together  with  smaller 
amounts  (20%) of unidentified polar 20:4 metabolites. Also evident are mono-HETE 
(fractions  (25-40)  and  components  with  elution  characteristics  (15)  of di-  and  tri- 
HETE.  Contrasting this situation, a  major percentage  (70%)  of the 20:4 released by 
i.p. CP  cells was  recovered  as unreacted  fatty acid.  As a  result,  prostaglandin and 
HETE  production were reduced proportionally. This finding indicates that the small 
percentage of 20:4 converted by i.p. CP macrophages to prostaglandins (Fig. 1) occurs 
because  of a  lack  of metabolism  rather  than  shunting  of the  fatty  acid  into  the 
lipoxygenase pathway. 
We next  examined  the cyclo-oxygenase products  formed by resident  and  i.p. CP 
macrophages. Resident cells synthesized 6-ketoPGFl~ and PGE2 in the ratio of 1:1.5 
(Fig. 6). PGE2 was also the major prostaglandin produced by i.p. CP populations, but 
the relative levels of 6-ketoPGF~ were reduced, and substantial amounts of a product 
with elution characteristics of TXB2 were recovered .The proportions of cyclo-oxygen- 1154  ACTIVATED MACROPHAGE ARACHIDONIC ACID METABOLISM 
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Fie. 4.  Effect of cultivation time on  (A) total 20:4 release and  (B) prostaglandin  synthesis by 
resident and i.p. CP macrophages. Cells purified by adherence were cultured in a-MEM plus 10% 
FCS for the indicated periods of time. During the final 16 h of cultivation, the cultures were labeled 
with  [aH]20:4. At the end of this period,  the cultures  were washed, overlaid with a-MEM, and 
exposed to  160 #g of zymosan. Media were removed from  duplicate cultures  and processed as 
described in Fig. 2. Values are the means :t: range. O, resident cells; 0, i.p, CP cells. 
ase metabolites of these CP-elicited cells was  1:4.1:16.8  for 6-ketoPGFa~, TXB2,  and 
PGE2. These qualitative and quantitative differences in prostaglandins formed by the 
two macrophage populations were evident in three separate experiments. 
In related experiments, the synthesis of leukotriene C  by macrophages from specific 
pathogen-free mice immunized i.p. with CP was 2-3% of resident cell controls (C. A, 
Rouzer, personal communication). 
Other Phagocytic Stimuli.  We  explored  the  question  of whether  20:4  metabolism 
promoted by a  zymosan challenge was representative of the macrophage response to 
phagocytic stimuli. For this purpose, 20:4 metabolism of cultured macrophages was 
compared after an in vitro challenge with zymosan, BCG, or CP. The kinetics of 20:4 
release and prostaglandin synthesis were similar to those shown  in Fig. 4, regardless 
of the stimulus.  Likewise, the same cyclo-oxygenase and lipoxygenase products were 
recovered. With resident cells, BCG promoted higher levels of 20:4 metabolism than 
did zymosan or CP at maximum stimulatory concentrations. However, BCG and CP 
at  these  levels  (1  mg/ml  and  1.2  mg/ml,  respectively) led to cell loss that  was  not 
evident with  zymosan.  Diminished prostaglandin synthesis by i.p. CP macrophages SCOTT  ET  AL. 
TABLE  I 
Phospholipid Fatty Acid Composition of Resident Macrophages and Activated 
Macrophages from Mice Injected i.p. with C. parvum 
1155 
Fatty acid 
Mol percent of fatty acid 
Resident cells  Activated cells 
14:0  3.6  2.4 
16:0  28.0  26.2 
16:1  2.0  5.3 
18:0  24.5  19.7 
18:1  10.0  10.5 
18:2  6.3  10.7 
20:4  25.7  25.0 
Saturated/unsaturated  0.78  1.07 
Cultures purified by adherence were incubated overnight in ~-MEM plus 10% 
FCS. The media were removed, and lipids were extracted from cells scraped 
into isotonic saline. Fatty acid analyses of isolated phospholipids were deter- 
mined by gas-liquid chromatography after transesterifieation. 
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Flo. 6.  Cyclo-oxygenase products synthesized by resident and i.p. CP macrophages. The prosta- 
glandin-containing  fractions (4-10) eluted from an ultrasphere  C-18 column (Fig. 5) were pooled, 
taken to dryness under a stream of nitrogen, and redissolved in solvent 3. Cyclo-oxygenase products 
were resolved on the same ultrasphere C-18 column with solvent 3 at a flow rate of 1 ml/min. Top 
panel, commercial radiolabeled standards;  middle panel, resident  macrophage  products;  bottom 
panel, i.p CP macrophage products. 
occured with all three phagocytic stimuli, and BCG and CP were clearly less effective 
than zymosan. 
In  Vitro Exposure of Resident Macrophages to Lymphokines.  Exposure to a  1-8 dilution 
of BCG  lymphokine  for  72  h  was  sufficient  to  morphologically  activate  resident 
macrophages.  However,  20:4  release  and  prostaglandin  (6-ketoPGFl~  and  PGE2) 
synthesis  by  such  cells  was  not  significantly  different  from  those  of controls  (no 
lymphokine) or cultures exposed to control supernatants.  Dose-response experiments 
in which  BCG  lymphokines were varied from  2  to  25%  in the culture medium  also 
failed to either enhance  or diminish  zymosan-mediated 20:4  metabolism.  A  similar 
lack of effect was noted when 20:4 metabolism was monitored at 24-h intervals during 
4-d cultivation of resident cells in a  1-8 dilution of BCG lymphokine. 
Modification of in  vivo activated cells to  release  20:4  products  therefore  reflects 
factors in addition to lymphokine-derived products. 
Discussion 
We previously concluded that resident peritoneal macrophages are a  major source 
of 20:4 metabolites. In this report, we examined the capacity of populations of in vivo SCOTT  ET  AL.  1157 
stimulated inflammatory macrophages to convert 20:4 to cyclo-oxygenase and lipox- 
ygenase products. We questioned whether a relationship exists between macrophage 
activation  and  the  level  of 20:4  production  in  response  to  an  in  vitro  phagocytic 
stimulus. As shown in Fig. 7, there is a correlation (r =  0.91) between the capacity to 
inhibit  intracellular  Toxoplasma gondii replication,  one measure  of macrophage  acti- 
vation (9), and decreased prostaglandin synthesis. This comparison included resident 
cells, macrophages  variously  activated  in vivo  with  BCG  or CP,  and  macrophages 
elicited  with  nonmicrobial  inflammatory  stimuli.  The  close  relationship  between 
diminished prostaglandin release and augmented toxoplasmastatic activity illustrates 
that decreased 20:4 metabolism is related to the degree of macrophage activation. 
Among the macrophage  populations  thus examined, THIO  cells represented  the 
single  exception  to  this  correlation.  It  is  likely  that  components  of THIO  broth 
directly  inhibited  the  production  of 20:4  metabolites  by  resident  cells  in  vitro,  as 
previously  found  (20)  for  H202  release  and  tumor  cell  destruction  by  activated 
macrophages.  The  fact  that  anti-toxoplasma  activity  was  spontaneously  lost  on 
prolonged cultivation (48 h) of i.p. CP cells (H. Murray, unpublished results) without 
a  concomitant  increase in zymosan-induced  20:4  metabolism  (Fig.  4)  suggested  the 
inverse relationship between these two macrophage activities is not necessarily causal. 2 
Diminished  macrophage  20:4 metabolism, as a result of activation, supported the 
notion  that  the  resident  tissue  macrophage  might  have  an  unique  role  in  acute 
inflammatory situations. This long-lived cell is undoubtedly one of the first elements 
of the immune system exposed to infection and tissue injury. As such, it can respond 
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Fro.  7.  Antitoxoplasma  activity  vs.  the capacity  for prostaglandin  synthesis  of resident,  inflam- 
matory, and activated macrophage populations. The abbreviations are those used in the text. The 
ordinate indicates the mean number of toxoplasms per intracellular vacuole  18 h after infection of 
macrophage cultures.  Thus,  the  greater  the  degree  of inhibition  of toxoplasma  replication,  the 
greater the degree of macrophage activation.  These  values were taken from an overlapping  study 
(9) in which common reagents were used to elicit cells for measurements of 20:4 oxygenated products 
and antitoxoplasma  activity, thus providing valid comparisons  for the two macrophage  functions. 
Data are provided for the eleven  macrophage  populations  in which both antitoxoplasma  activity 
and PGE2 synthesis resulting from a maximum zymosan stimulus were measured. Values for PGE2 
release are given in the text, except for BiG-activated cells. Methods for the determination of PGE2 
synthesis by these macrophage populations are given in Materials and Methods or in the legend to 
Fig.  1.  In  calculating  the  correlation  coefficient  between  reduced  antitoxoplasma  activity  and 
enhanced capacity for prostaglandin synthesis, data for THIO macrophages were omitted. 
2 This point is further emphasized from studies of in vitro activated macrophages obtained by lymphokine 
treatment.  Although the high level of 20:4 metabolism  and failure to inhibit toxoplasma replication  (9) 
provided the  expected  correlation  (Fig.  7),  lymphokine induces  resident  macrophages  to  destroy  other 
intracellular parasites [L. enrietti  (21)  and T. cruzi (22)]. 1158  ACTIVATED  MACROPtlAGE ARACHIDONIC ACID  METABOLISM 
to  inflammatory  stimuli  in  the  absence  of  humoral  factors  by  producing  large 
quantities  of 20:t oxygenated products  (Table  II)  that  can  have  immediate  conse- 
quences on the  vasculature  (23)  and  on  the  immune system  (24).  The considerable 
synthetic capacity of the macrophage is compared in Table Ii with that of guinea pig 
neutrophils  for which similar quantitative  data are available. 
Activated  macrophages,  as shown  in  this  study  for i.p.  CP cells,  responded  to in 
vitro inflammatory stimuli by a  burst of 20:4 release and the subsequent  synthesis of 
cyclo-oxygenase and  lipoxygenase products.  Although their phagocytic capacity ap- 
pears  unimpaired  (W. A. Scott, unpublished  results),  20:4 metabolism  was reduced. 
Down regulation was evident at the level of the inducible phospholipase.  In addition, 
there  is  a  failure  to  quantitatively  metabolize  released  20:4  together  with  specific 
inactivation  (or inhibition)  of the prostacyclin synthetase,  as noted earlier  (19), and 
of enzyme(s)  for leukotriene  C  synthesis.  The  implication  of these  findings  is  that 
activated  macrophages  within  chronic  inflammatory  foci  release  a  mixture  of 20:4 
metabolites  distinct  from resident  cells  (Table II). The elimination  of the vasoactive 
agents prostacyclin and leukotriene C, coupled with an overall reduction in synthetic 
capacity, might be a  factor in limiting the immune response. Activated macrophages, 
however,  might  continue  to  be  a  considerable  source  of  20:4  metabolites  when 
compared to other cell types (Table II). 
The  factors  that  regulate  macrophage  20:4 metabolism  remain  to be elucidated. 
Our results  suggest  from  a  comparison  of i.p.  CP  and  i.v.  CP cells  that  a  reduced 
synthetic capacity is a localized response to bacterial antigens. The lessened production 
TABLE II 
Arachidonic Acid Metabolites 
Amount 
produced  References  Cell type  Stimulus  Product  (pmol/mg cell 
protein) 
Resident mouse  160 ~g zymosan  PGE2  12,000-15,500  Scott et al. (1) 
peritoneal macrophage  6-keto PGF1~  5,000-7,000 
HETE  2,500-4,000 
Leukotriene C  .3~000-6~000  Rouzer et al. (2) 
23,200-31,700 
C. parvum-elicited  160/~g zymosan  PGE2  2,500-3,500 
mouse peritoneal  6-keto PGF1,  100-200 
macrophages  TXB2  600- 700 
HETE  700- 1,000 
Leukotriene C  80-110 
3,900-5,400 
Guinea pig  10  -s M calcium  PGE2  1.9  Bokoch and Reed (26) 
neutrophils  Ionophore  6-keto PGF1,  0.9 
A23,187  TXB2  10.2 
PGFz~  0.95 
5-HETE  30.2 
44.15 SCOTT ET AL.  1159 
after an  i.p.  administration  of BCG or CP  might result because macrophages have 
undergor]e a round of 20:4 release and metabolism in vivo (25). This point of view is 
supported by the finding that both bacteria are potent triggers of macrophage 20:4 
metabolism. Clearly, additional factors are involved in regulating macrophage 20:4 
metabolism, as shown by the priming effect of a  systemic (i.v.)  immunization when 
followed by an i.p. boost. 20:4 metabolism by the resulting macrophage population 
was  decreased significantly below that  of cells from nonimmune animals given the 
same boosting injection. In vitro activation of macrophages with spleen cell products 
indicated that factors in addition to lymphokines are required to regulate the release 
of 20:4 products. 
It  is  now appropriate  to examine the relative contributions of several variables, 
such  as  the  rates  of antigen  clearance  and  deposition,  the  influx of mononuclear 
phagocytes into the inflammatory site, and  the role of the host  immune system, in 
controlling the synthesis of inflammatory lipids by macrophages. 
Summary 
Levels  of zymosan-induced  arachidonic  acid  (20:4)  metabolism  by  peritoneal 
macrophages  elicited  with  inflammatory  agents  and  resident  macrophages  were 
similar.  Thyioglycollate  (THIO)-elicited  macrophages  represented  the  exception; 
however,  the  diminished  metabolism  by  these  cells  was  reproduced  by  exposing 
resident cells to 5  mg/ml THIO broth in  vitro. In contrast, reduced prostaglandin 
synthesis by macrophages from mice variously treated with the immunologic agents, 
Cornbacterium  parvum  or Bacille Calmette Gu~rin  (BCG), closely correlated with  en- 
hanced  antitoxoplasma activity, one measure of macrophage activation. This rela- 
tionship, although not causative, suggested that the capacity for 20:4 metabolism is 
a  function  of the  macrophage  activation  state.  Modulation  of macrophage  20:4 
metabolism  in  vivo apparently  required  factors in  addition  to lymphocyte-derived 
products.  Treatment  of resident  macrophages  in  vitro with  BCG  lymphokine was 
without effect on 20:4 release or prostaglandin synthesis. 
Activated  macrophages  from  animals  inoculated  i.p.  with  C.  parvum  exhibited 
reduced 20:4 release and also failed to metabolize 70% of the 20:4 released in response 
to a zymosan stimulus. Consequently, the quantities of 20:4 metabolites formed were 
significantly  less  than  expected  from  20:4  release.  These  activated  macrophages 
displayed greatly reduced synthesis of prostacylcin and leukotriene C compared with 
other  20:4  metabolites.  It  appeared  that  factors  that  regulate  macrophage  20:4 
metabolism influence the level of the inducible phospholipase and synthetic enzymes 
for specific 20:4 oxygenated products. 
Received  for publication 7 December 1981. 
References 
1.  Scott, W. A., J. M. Zrike, A. L. Hamill, J. Kempe, and Z. A. Cohn.  1980. Regulation of 
arachidonic acid metabolites  in macrophages.J. Exp.  Med. 152:324. 
2.  Rouzer, C. A., W. A. Scott, A. L. Hamill, and Z. A. Cohn.  1980. Dynamics of leukotriene 
C production by macrophages.J. Exp.  Med. 152:1236. 
3.  Rouzer, C. A., W. A. Scott, J. Kempe, and Z. A. Cohn.  1980. Prostaglandin synthesis by 
macrophages requires  a specific receptor ligand  interaction. Proe. Natl.  Acad. Sci  U.  S.  A. 
77:4279. 
4.  Cohn, Z. A.  1978. The activation of mononuclear phagocytes:  fact, fancy and future. J. 
Immunol. 121:813. 1160  ACTIVATED MACROPHAGE  ARACHIDONIC ACID METABOLISM 
5.  North, R.J.  1978. The concept of the activated macrophage.J. Immunol.  121:806. 
6.  Karnovsky, M. L., andJ. K. Lazdins. 1978. Biochemical criteria for activated macrophages. 
J. Immunol.  121:809. 
7.  Silverstein, S. C., R. M. Steinman, and Z. A. Cohn.  1977. Endocytosis. Ann.  Rev.  Biochem. 
46:669. 
8.  Cohn,  Z.  A.,  and  B.  Benson.  1965. The  differentiation  of  mononuclear  phagocytes. 
Morphology, cytochemistry, and biochemistry.J. Exp. Med.  121:153. 
9.  Murray,  H.  W.,  and  Z.  A.  Cohn.  1980. Macrophage  oxygen-dependent  antimicrobial 
activity III. Enhanced oxidative metabolism as an expression of macrophage activation. J. 
Exp. Med.  152:1596. 
10.  Lowry, O. H., N.J. Roseborough, A. J. Farr, and R.J. Randall. 1951. Protein measurement 
with Folin phenol reagent. J. Biol.  Chem. 193:265. 
11.  Unger, W. G., I. F. Stamford, and A. Bennetti.  1971. Extraction of prostaglandins from 
human blood. Nature (Lond.).  233:336. 
12.  Alam, I., K. Ohuchi, and L. Levine. 1979. Determinatioin ofcyclo-oxygenase products and 
prostaglandin  metabolites using  high-pressure  liquid chromatography  and  radioimmu- 
noassay. Anal,  Biochem. 93:339. 
13.  Mahoney, E. M., A. L. Hamill, W. A. Scott, and Z. A. Cohn.  1977. Response ofendocytosis 
to  altered  fatty  acid  composition  of  macrophage  phospholipids.  Proc. Natl.  Acad.  Sci. 
U. S. A. 74:4895. 
14.  Rouzer, C. A., W. A. Scott, O. W. Griffith, A. L. Hamill, and Z. A. Cohn.  1981. Depletion 
of glutathione selectively inhibits synthesis of leukotriene C  by macrophages. Proc. Natl. 
Acad.  Sci.  U. S. A. 78:2532. 
15.  Borgeat, P., and B. Samuelsson. 1979. Arachidonie acid metabolism in polymorphonuclear 
leukocytes: effects ofionophore A 23187.  Proc. Natl. Acad.  Sci.  U. S. A.  76:2148. 
16.  Hamburg, M., and B. Samuelsson. 1974. Prostaglandin endoperoxides. Novel transforma- 
tions of arachidonic acid in human platelets. Proc. Natl. Acad.  Sci.  U. S. A. 71:3400. 
17.  Funk,  M.  O.,  R.  Isaac, and  N.  A.  Porter.  1976. Preparation  and  purification of lipid 
hydroperoxides from arachidonic and 3,-linolenic acids. Lipids.  11:113. 
18.  Bonney, R. J.,  P.  D. Wightman, P.  Davies, S. J.  Sadowski, F. A. Kuehl, Jr.,  and J.  L. 
Humes.  1978. Regulation of prostaglandin synthesis and of the select release of lysosomal 
hydrolases by mouse peritoneal macrophages. Biochem. J.  176:433. 
19.  Humes, J. L., S. Burger, M, Galavage, F. A. Kuehl, Jr., P. D. Wightman, M. E. Dahlgren, 
P.  Davies,  and  R.  J.  Bonney.  1980. The  diminished  production  of arachidonic  acid 
oxygenated products by elicited mouse peritoneal macrophages: possible mechanisms. J. 
Immunol.  124:2110. 
20.  Nathan, C., and Z. A. Cohn.  1980. Role of oxygen-dependent mechanisms in antibody- 
induced lysis of tumor cells by activated macrophages. J. Exp. Med.  152:198. 
21.  Buchmuller, Y., and J. Mauel. 1979. Studies on the mechanism of macrophage activation. 
II.  Parasite  destruction  in  macrophages  activated by supernates  from  concanavalin A- 
stimulated lymphocytes.J. Exp. Med.  150:359. 
22.  Nogueira, N., and Z. A. Cohn.  1978. Trypanosoma cruzi: in vitro induction of macrophage 
microbicidal activity. J. Exp. Med.  148:288. 
23.  Samuelsson,  B.,  M.  Goldyne,  E.  Granstr/Sm,  M.  Hamburg,  S.  Hammarstr/Sm,  and  C. 
Malmstem.  1978. Ann.  Rev.  Biochem. 47:997. 
24.  Kuehl, Jr., F. A., and R. W. Egan.  Prostaglandins, arachidonic acid, and inflammation. 
Science (Wash. D. C.). 210:978. 
25.  Stenson, W. F., and C. W. Parker.  1980. Prostaglandins, macrophages, and immunity. J. 
Immunol.  125:1. 
26.  Bokoch, G.  M.,  and  P.  W.  Reed.  1980. Stimulation of arachidonic acid metabolism in 
polymorphonuclear leukocytes by an N-formulated peptide. J. Biol.  Chem. 255:10223. 